Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
5.47B | 5.76B | 5.22B | 5.12B | 3.33B | Gross Profit |
2.22B | 1.66B | 1.37B | 1.66B | 970.00M | EBIT |
-546.00M | -583.00M | -749.00M | -976.00M | -609.00M | EBITDA |
4.94B | 5.30B | 9.90B | 730.00M | 213.00M | Net Income Common Stockholders |
6.61B | 10.11B | 18.73B | 7.45B | 3.77B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
18.99B | 20.87B | 13.57B | 6.03B | 8.02B | Total Assets |
61.82B | 65.08B | 71.34B | 55.73B | 35.77B | Total Debt |
16.24B | 16.91B | 17.16B | 9.12B | 3.97B | Net Debt |
14.06B | 7.34B | 7.52B | 5.54B | -207.00M | Total Liabilities |
20.53B | 20.45B | 20.82B | 12.54B | 6.46B | Stockholders Equity |
41.26B | 44.59B | 50.42B | 43.07B | 29.10B |
Cash Flow | Free Cash Flow | |||
978.00M | -349.00M | -817.00M | 54.00M | -310.00M | Operating Cash Flow |
1.04B | -120.00M | -605.00M | 159.00M | -209.00M | Investing Cash Flow |
209.00M | 12.64B | 4.39B | -3.22B | 2.33B | Financing Cash Flow |
-8.12B | -12.45B | 2.40B | 2.45B | -46.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $16.71B | 9.13 | 47.49% | ― | 19.35% | ― | |
74 Outperform | $21.24B | 20.00 | 10.75% | 1.11% | 0.63% | 34.09% | |
70 Outperform | $72.81B | 648.38 | 1.68% | ― | 24.17% | ― | |
68 Neutral | $29.56B | 9.28 | 9.14% | ― | -2.60% | 16.71% | |
67 Neutral | $92.70B | 13.43 | 18.15% | 0.19% | 16.14% | ― | |
66 Neutral | $18.39B | ― | -27.12% | ― | 61.71% | -442.46% | |
58 Neutral | $13.15B | 6.73 | -2.46% | 3.87% | 2.36% | -36.74% |